These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8204254)

  • 21. [Cyclosporin A in the treatment of Eaton-Lambert myasthenic syndrome].
    Yuste Ara JR; Beloqui Ruiz O; Artieda Gonzalez-Granda J; Herrero Santos JI; De la Peña Fernandez A; Prieto Valtueña J
    An Med Interna; 1996 Jan; 13(1):25-6. PubMed ID: 8679819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The treatment of the Eaton-Lambert myasthenic syndrome with 3,4-diaminopyridine].
    Casanova B; Vílchez JJ; Rubio P
    Rev Clin Esp; 1993 Apr; 192(7):354-5. PubMed ID: 8388576
    [No Abstract]   [Full Text] [Related]  

  • 23. Lambert-Eaton myasthenic syndrome associated with idiopathic thrombocytopenic purpura and diffuse panbronchiolitis: long-term remission after a course of intravenous immunoglobulin combined with low-dose prednisolone.
    Takata T; Koide S; Ogata K; Motomura M; Yoshimura T; Hanajima R; Sakurai M; Kanazawa I
    Am J Med Sci; 1999 Nov; 318(5):353-5. PubMed ID: 10555101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lambert-Eaton myasthenic syndrome in childhood.
    Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Lambert-Eaton syndrome with intravenous immunoglobulin.
    Rich MM; Teener JW; Bird SJ
    Muscle Nerve; 1997 May; 20(5):614-5. PubMed ID: 9140371
    [No Abstract]   [Full Text] [Related]  

  • 26. Lambert-Eaton myasthenic syndrome: Epidemiology and therapeutic response in the national veterans affairs population.
    Abenroth DC; Smith AG; Greenlee JE; Austin SD; Clardy SL
    Muscle Nerve; 2017 Sep; 56(3):421-426. PubMed ID: 27997683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Successful treatment of a Lambert-Eaton myasthenic syndrome patient with 3,4-diaminopyridine].
    Matsushima M; Yaguchi H; Kishimoto R; Tsuji S; Yabe I; Sasaki H; Nakadate M; Shiraishi H; Motomura M
    Nihon Naika Gakkai Zasshi; 2007 Aug; 96(8):1709-11. PubMed ID: 17802724
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hodgkin's disease with systemic vasculitis and Lambert-Eaton myasthenic syndrome--case report].
    Homenda W; Hellmann A
    Wiad Lek; 2000; 53(9-10):574-8. PubMed ID: 11148928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The drug treatment of the Lambert-Eaton myasthenic syndrome].
    Danilov AF
    Eksp Klin Farmakol; 1999; 62(6):69-71. PubMed ID: 10650534
    [No Abstract]   [Full Text] [Related]  

  • 30. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Muscle Nerve; 2005 Apr; 31(4):487-94. PubMed ID: 15685615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on the evaluation and therapy of autoimmune neuromuscular junction disorders.
    Katz J; Barohn RJ
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):381-97. PubMed ID: 11345014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lambert-Eaton (myasthenic) syndrome: pre-anaesthetic treatment with intravenous immunoglobulins.
    Biarnés A; Rochera MI
    Anaesthesia; 1996 Aug; 51(8):797. PubMed ID: 8795338
    [No Abstract]   [Full Text] [Related]  

  • 33. Current therapy of the Lambert-Eaton myasthenic syndrome.
    Lundh H; Nilsson O; Rosén I
    Prog Brain Res; 1990; 84():163-70. PubMed ID: 2267294
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and electrophysiologic improvement in Lambert-Eaton syndrome with intravenous immunoglobulin therapy.
    Bird SJ
    Neurology; 1992 Jul; 42(7):1422-3. PubMed ID: 1620360
    [No Abstract]   [Full Text] [Related]  

  • 35. Lambert-Eaton Myasthenic Syndrome Plus.
    Costa MR; Maruta C; de Carvalho M
    J Clin Neuromuscul Dis; 2019 Dec; 21(2):119-121. PubMed ID: 31743258
    [No Abstract]   [Full Text] [Related]  

  • 36. Lambert-Eaton myaesthenic syndrome: a possible association with Hodgkin's lymphoma.
    Tyagi A; Connolly S; Hutchinson M
    Ir Med J; 2001 Jan; 94(1):18-9. PubMed ID: 11322220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful alternate day guanidine therapy following guanidine-induced neutropenia in the Lambert-Eaton myasthenic syndrome.
    Silbert PL; Hankey GJ; Barr AL
    Muscle Nerve; 1990 Apr; 13(4):360-1. PubMed ID: 2355949
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary respiratory failure as the presenting symptom in Lambert-Eaton myasthenic syndrome.
    Barr CW; Claussen G; Thomas D; Fesenmeier JT; Pearlman RL; Oh SJ
    Muscle Nerve; 1993 Jul; 16(7):712-5. PubMed ID: 8505927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A close look at autoimmune muscle disorders: association of Lambert-Eaton myasthenic syndrome with dermatomyositis.
    Mössner R; Tings T; Beckmann I; Neumann C; Paulus W; Reich K
    Scand J Rheumatol; 2004; 33(4):271-5. PubMed ID: 15370725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lambert-Eaton myasthenic syndrome associated with thymitis.
    Warren NM; Bennett M; Lai M; Forty J; Walls TJ
    Neurology; 2005 Jan; 64(1):168-9. PubMed ID: 15642933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.